E X E CUTIVE OFFICE OF THE PRESIDENT

OFFICE OF NATIONAL DRUG CONTROL POLICY

2 CFR 3603 et seq.

Semiannual Regulatory Agenda

AGENCY: Office of National Drug Control Policy

ACTION: Semiannual regulatory agenda.

SUMMARY: The Regulatory Fl e x ibility Act of 1980 and Executive Order (EO) 12866 require

the semiannual issuance of an inventory of rulemaking actions under development throughout

the Department , offering for public review summari z ed information about forthcoming regulatory actions

.

FOR FURTHER INFORMATION CONTACT: For general information, please contact Daniel Rader, Deputy General Counsel, Office of Legal Counsel, Office of National Drug Control Policy, Executive Office of the President, 750 17 th Street NW., Room 506, Washington, DC 20503 or via telephone 202-395-6621.

SUPPLEMENTARY INFORMATION: The White House Office of National Drug Control Policy (ONDCP), a component of the Executive Office of the President, was established by the Anti-Drug Abuse Act of 1988. The principal purpose of ONDCP is to establish policies, priorities, and objectives for the Nation'sdrug con tr ol program. The goals of the program are to reduce illicit drug use, manufacturing, and

trafficking, drug-related crime and violence, and drug- re lated health consequences. To achieve these goals, the Director of ONDCP is charged with producing the National Drug Control Strategy. The Strategy directs the Nation's anti-drug efforts and establishes a program, a budget, and guidelines for cooperation among Federal, State, and local entities.

By law, the Director of ONDCP also evaluates, coordinates, and oversees both the international and domestic anti-drug efforts of Executive Branch Agencies and ensures that such efforts sustain and complement State and local anti-drug activities. The Director advises the President regarding changes in the organization, management, budgeting, and personnel of Federal Agencies that could affect the Nation's anti-drug efforts; and regarding Federal agency compliance with their obligations under the strategy.

This Agenda presents the rulemaking activities that the ONDCP currently expects to undertake this year to advance the Strategy

. Pursuant to authorities under 21 U.S.C. 1701, et

seq. , 21 U.S.C. 1521 et seq , and 2 CFR parts 200, and 3603 et seq ., and pursuant to the Strategy and appropriations acts of Congress provides financial assistance in the form of grants and cooperative agreements to a variety of organizations, including but not limited to State and local governments, colleges and universities, and non-profits. ONDCP’s interim final regulations , 2 CFR 3603 et seq, adopting the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards published in 79 FR 76195 (Dec. 19, 2014), will be finalized by Sept. 30, 2015. (Regulation Identification Number (RIN) 3201-AA00).

ADDRESSES: Public comments should be submitted to FN -ONDCP-FedRegisterInputs@ondcp.eop.gov with the email subject heading “Regulatory Agenda Comments .”

Dated: April 8, 2015.NA M E: Daniel S. Rader, Deputy General Counsel.The 1 Regulatory Agendas

Office of National Drug Control Policy - Long-term Action

Title Regulation Identifier Number Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards 3201-AA00

Executive Office of the President (EOP) Office of National Drug Control Policy ( ODNCP ) RIN: 3201-AA00

View Related Documents

Title: Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards Abstract: ONDCP conforming regulations for agency implementation of the OMB Omni-Circular, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards, 2 CFR part 200. Priority: Substantive, Nonsignificant Agenda Stage of Rulemaking: Long-term Action Major: Undetermined Unfunded Mandates: No CFR Citation: 2 CFR 3603; 21 CFR 1403 to 1405 (To search for a specific CFR, visit the Code of Federal Regulations ) Legal Authority: Not Yet Determined Legal Deadline: None

Timetable: Action Date FR Cite Next Action Undetermined Interim Final Rule 12/19/2014 79 FR 75872 Interim Final Rule Effective 12/26/2014

Regulatory Flexibility Analysis Required: No Government Levels Affected: No Federalism: No Energy Affected: No Agency Contact: Daniel S. Rader Deputy General Counsel Executive Office of the President Office of National Drug Control Policy

Phone: 202 395-6621 E-Mail: drader@ondcp.eop.gov